Литература Aalkjaer C, Mulvany mj, Nyborg nc. Atrial natriuretic factor causes specific relaxation of rat renal arcuate arteries

J Physiol. 2001;533(Pt 1):273-280.

Suzuki E, Hirata Y, Hayakawa H, Omata M, Kojima M, Kangawa K, Minamino N, Matsuo H. Evidence for C-type natriuretic peptide production in the rat kidney. Biochem Biophys Res Commun. 1993;192(2):532-538. doi: 10.1006/bbrc.1993.1448

Tajima M, Bartunek J, Weinberg EO, Ito N, Lorell BH. Atrial natriuretic peptide has different effects on contractility and intracellular pH in normal and hypertrophied myocytes from pressure-overloaded hearts. Circulation. 1998;98(24):2760-2764.

Takei Y, Takahashi A, Watanabe TX, Nakajima K, Sakakibara S. A novel natriuretic peptide isolated from eel cardiac ventricles. FEBS Lett. 1991;282(2):317-320.

Takekoshi K, Ishii K, Isobe K, Nomura F, Nammoku T, Nakai T. Effects of natriuretic peptides (ANP, BNP, CNP) on catecholamine synthesis and TH mRNA levels in PC12 cells. Life Sci. 2000;66(22):PL303-PL311.

Takemura G, Fujiwara H, Horike K, Mukoyama M, Saito Y, Nakao K, Matsuda M, Kawamura A, Ishida M, Kida M, et al. Ventricular expression of atrial natriuretic polypeptide and its relations with hemodynamics and histology in dilated human hearts. Immunohistochemical study of the endomyocardial biopsy specimens. Circulation. 1989;80(5):1137-1147.

Takeshita A, Imaizumi T, Nakamura N, Higashi H, Sasaki T, Nakamura M, Kangawa K, Matsuo H. Attenuation of reflex forearm vasoconstriction by alpha-human atrial natriuretic peptide in men. Circ Res. 1987;61(4):555-559.

Tamura N, Ogawa Y, Yasoda A, Itoh H, Saito Y, Nakao K. Two cardiac natriuretic peptide genes (atrial natriuretic peptide and brain natriuretic peptide) are organized in tandem in the mouse and human genomes. J Mol Cell Cardiol. 1996;28(8):1811-1815. doi: 10.1006/jmcc.1996.0170

Tamura N, Ogawa Y, Chusho H, Nakamura K, Nakao K, Suda M, Kasahara M, Hashimoto R, Katsuura G, Mukoyama M, Itoh H, Saito Y, Tanaka I, Otani H, Katsuki M. Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc Natl Acad Sci USA. 2000;97(8):4239-4244. doi:10.1073/pnas.070371497

Telegdy G. The action of ANP, BNP and related peptides on motivated behavior in rats. Rev Neurosci. 1994;5(4):309-315.

Terada Y, Moriyama T, Martin BM, Knepper MA, Garcia-Perez A. RT-PCR microlocalization of mRNA for guanylyl cyclase-coupled ANF receptor in rat kidney. Am J Physiol. 1991;261(6 Pt 2): F1080-F1087.

Ter-Avetisyan G, Rathjen FG, Schmidt H. Bifurcation of axons from cranial sensory neurons is disabled in the absence of Npr2-induced cGMP signaling. J Neurosci. 2014;34(3):737-747. doi: 10.1523/JNEUROSCI.4183-13.2014

Theilig F, Wu Q. ANP-induced signalling cascade and its implications in renal pathophysiology. Am J Physiol Renal Physiol. 2015;308(10):F1047-F1055. doi: 10.1152/ajprenal.00164.2014

Thibault G, Charbonneau C, Bilodeau J, Schiffrin EL, Garcia R. Rat brain natriuretic peptide is localized in atrial granules and released into the circulation. Am J Physiol. 1992;263(2 Pt 2):R301-R309.

Thomas CJ, Woods RL. Guanylyl cyclase receptors mediate cardiopulmonary vagal reflex actions of ANP. Hypertension. 2003;41(2):279-285.

Thomas CJ, McAllen RM, Salo LM, Woods RL. Restorative effect of atrial natriuretic peptide or chronic neutral endopeptidase inhibition on blunted cardiopulmonary vagal reflexes in aged rats. Hypertension. 2008;52(4):696-701. doi: 10.1161/HYPERTENSIONAHA.108.111302

Thorén P, Morgan DA, O’Neill TP, Needleman P, Mark AL, Brody MJ. Atrial natriuretic factor activates vagal afferents in rats. Fed Proc. 1985;44(6):1886.

Thorén P, Mark AL, Morgan DA, O’Neill TP, Needleman P, Brody MJ. Activation of vagal depressor reflexes by atriopeptins inhibits renal sympathetic nerve activity. Am J Physiol. 1986;251(6 Pt 2):H1252-H1259.

Thygesen K, Mair J, Mueller C, Huber K, Weber M, Plebani M, Hasin Y, Biasucci LM, Giannitsis E, Lindahl B, Koenig W, Tubaro M, Collinson P, Katus H, Galvani M, Venge P, Alpert JS, Hamm C, Jaffe AS. Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Eur Heart J. 2012;33(16):2001-2006. doi: 10.1093/eurheartj/ehq509

Tohse N, Nakaya H, Takeda Y, Kanno M. Cyclic GMP-mediated inhibition of L-type Ca2+ channel activity by human natriuretic peptide in rabbit heart cells. Br J Pharmacol. 1995;114(5):1076-1082.

Tokudome T, Horio T, Soeki T, Mori K, Kishimoto I, Suga S, Yoshihara F, Kawano Y, Kohno M, Kangawa K. Inhibitory effect of C-type natriuretic peptide (CNP) on cultured cardiac myocyte hypertrophy: interference between CNP and endothelin-1 signaling pathways. Endocrinology. 2004;145(5):2131-2140. doi: 10.1210/en.2003-1260

Torda T, Nazarali AJ, Saavedra JM. Brain natriuretic peptide receptors in the rat peripheral sympathetic ganglia. Biochem Biophys Res Commun. 1989;159(3):1032-1038.

Towler DA. Molecular and cellular aspects of calcific aortic valve disease. Circ Res. 2013;113(2):198-208. doi: 10.1161/CIRCRESAHA.113.300155

Trachte GJ, Kanwal S, Elmquist BJ, Ziegler RJ. C-type natriuretic peptide neuromodulates via «clearance» receptors. Am J Physiol. 1995;268(4 Pt 1):978-984.

Tsuneyoshi H, Nishina T, Nomoto T, Kanemitsu H, Kawakami R, Unimonh O, Nishimura K, Komeda M. Atrial natriuretic peptide helps prevent late remodeling after left ventricular aneurysm repair. Circulation. 2004;110(11 Suppl 1):II174- II179. doi: 10.1161/01.CIR.0000138348.77856.ef

Tucker VL, Simanonok KE, Renkin EM. Tissue-specific effects of physiological ANP infusion on blood-tissue albumin transport. Am J Physiol. 1992;263(4 Pt 2):R945-R953.

Ueda S, Minamino N, Aburaya M, Kangawa K, Matsukura S, Matsuo H. Distribution and characterization of immunoreactive porcine C-type natriuretic peptide. Biochem Biophys Res Commun. 1991;175(3):759-767.

Ueda S, Minamino N, Sudoh T, Kangawa K, Matsuo H. Regional distribution of immunoreactive brain natriuretic peptide in porcine brain and spinal cord. Biochem Biophys Res Commun. 1988;155(2):733-739.

Ueno H, Haruno A, Morisaki N, Furuya M, Kangawa K, Takeshita A, Saito Y. Local expression of C-type natriuretic peptide markedly suppresses neointimal formation in rat injured arteries through an autocrine/paracrine loop. Circulation. 1997;96(7):2272-2279.

Unger T, Badoer E, Gareis C, Girchev R, Kotrba M, Qadri F, Rettig R, Rohmeiss P. Atrial natriuretic peptide (ANP) as a neuropeptide: interaction with angiotensin II on volume control and renal sodium handling. Br J Clin Pharmacol. 1990;30(Suppl 1):83S-88S.

Valentin JP, Ribstein J, Mimran A. Effect of nicardipine and atriopeptin on transcapillary shift of fluid and proteins. Am J Physiol. 1989;257(1 Pt 2):R174-R179.

Vasques GA, Arnhold IJ, Jorge AA. Role of the natriuretic peptide system in normal growth and growth disorders. Horm Res Paediatr. 2014;82(4):222-229. doi: 10.1159/000365049

Vaxelaire JF, Laurent S, Lacolley P, Briand V, Schmitt H, Michel JB. Atrial natriuretic peptide decreases contractility of cultured chick ventricular cells. Life Sci. 1989;454(1):41-48.

Villar IC, Panayiotou CM, Sheraz A, Madhani M, Scotland RS, Nobles M, Kemp-Harper B, Ahluwalia A, Hobbs AJ. Definitive role for natriuretic peptide receptor-C in mediating the vasorelaxant activity of C-type natriuretic peptide and endothelium-derived hyperpolarising factor. Cardiovasc Res. 2007;74(3):515-525. doi: 10.1016/j.cardiores.2007.02.032

Vink S, Jin AH, Poth KJ, Head GA, Alewood PF. Natriuretic peptide drug leads from snake venom. Toxicon. 2012;59(4):434-445. doi: 10.1016/j.toxicon.2010.12.001

Vlasuk GP, Babilon RW, Nutt RF, Ciccarone TM, Winquist RJ. The actions of atrial natriuretic factor on the vascular wall. Can J Physiol Pharmacol. 1987;65(8):1684-1689.

Vollmar AM, Paumgartner G, Gerbes AL. Differential gene expression of the three natriuretic peptides and natriuretic peptide receptor subtypes in human liver. Gut. 1997;40(1):145-150.

Volpe M, Rubattu S, Burnett J. Natriuretic peptides in cardiovascular diseases: current use and perspectives. Eur Heart J. 2014;35(7):419-425. doi: 10.1093/eurheartj/eht466

Volpe M, Carnovali M, Mastromarino V. The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment. Clin Sci. (Lond). 2016;130(2):57-77. doi: 10.1042/CS20150469

Wallace DP, Rome LA, Sullivan LP, Grantham JJ. cAMP-dependent fluid secretion in rat inner medullary collecting ducts. Am J Physiol Renal Physiol. 2001;280(6):F1019-F1029.

Wang TJ, Larson MG, Keyes MJ, Levy D, Benjamin EJ, Vasan RS. Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals. Circulation. 2007;115(11):1345-1353. doi: 10.1161/CIRCULATIONAHA.106.655142

Watanabe S, Shite J, Takaoka H, Shinke T, Imuro Y, Ozawa T, Otake H, Matsumoto D, Ogasawara D, Paredes OL, Yokoyama M. Myocardial stiffness is an important determinant of the plasma brain natriuretic peptide concentration in patients with both diastolic and systolic heart failure. Eur Heart J. 2006;27(7):832-838. doi: 10.1093/eurheartj/ehi772

Webb DJ, Benjamin N, Allen MJ, Brown J, O’Flynn M, Cockcroft JR. Vascular responses to local atrial natriuretic peptide infusion in man. Br J Clin Pharmacol. 1988;26(3):245-251.

Weber NC, Blumenthal SB, Hartung T, Vollmar AM, Kiemer AK. ANP inhibits TNF-alpha-induced endothelial MCP-1 expression-involvement of p38 MAPK and MKP-1. J Leukoc Biol. 2003;74(5):932-941. doi: 10.1189/jlb.0603254

Wei CM, Heublein DM, Perrella MA, Lerman A, Rodeheffer RJ, McGregor CG, Edwards WD, Schaff HV, Burnett JC. Natriuretic peptide system in human heart failure. Circulation. 1993;88(3):1004-1009.

Weninger S, De Maeyer JH, Lefebvre RA. Study of the regulation of the inotropic response to 5-HT4 receptor activation via phosphodiesterases and its cross-talk with C-type natriuretic peptide in porcine left atrium. Naunyn Schmiedebergs Arch Pharmacol. 2012;385(6):565-577. doi: 10.1007/s00210-012-0746-y

Wiley KE, Davenport AP. Physiological antagonism of endothelin-1 in human conductance and resistance coronary artery. Br J Pharmacol. 2001;133(4):568-574. doi: 10.1038/sj.bjp.0704119

Winquist RJ, Faison EP, Nutt RF. Vasodilator profile of synthetic atrial natriuretic factor. Eur J Pharmacol. 1984;102(1):169-173.

Winquist RJ. The relaxant effects of atrial natriuretic factor on vascular smooth muscle. Life Sci. 1985;37(12):1081-1087.

Wollert KC, Yurukova S, Kilic A, Begrow F, Fiedler B. Increased effects of C-type natriuretic peptide on contractility and calcium regulation in murine hearts overexpressing cyclic GMP-dependent protein kinase I. Br J Pharmacol. 2003;140(7):1227-1236. doi: 10.1038/sj.bjp.0705567

Wu C, Wu F, Pan J, Morser J, Wu Q. Furin-mediated processing of Pro-C-type natriuretic peptide. J Biol Chem. 2003;278(28):2584-2552. doi: 10.1074/jbc.M301223200

Yamamoto S, Inenaga K, Eto S, Yamashita H. Cardiovascular-related peptides influence hypothalamic neurons involved in control of body water homeostasis. Obes Res. 1995;3(Suppl 5):789S-794S.

Yamamoto S, Morimoto I, Yanagihara N, Kangawa K, Inenaga K, Eto S, Yamashita H. C-type natriuretic peptide suppresses arginine-vasopressin secretion from dissociated magnocellular neurons in newborn rat supraoptic nucleus. Neurosci Lett. 1997;229(2):97-100.

Yandle TG, Richards AM, Nicholls MG, Cuneo R, Espiner EA, Livesey JH. Metabolic clearance rate and plasma half-life of alpha-human atrial natriuretic peptide in man. Life Sci. 1986;38(20):1827-1833.

Yasoda A, Nakao K. Translational research of C-type natriuretic peptide (CNP) into skeletal dysplasias. Endocr J. 2010;57(8): 566-659.

Yoshizumi M, Tsuji H, Nishimura H, Masuda H, Kunieda Y, Kawano H, Kimura S, Sugano T, Kitamura H. Natriuretic peptides regulate the expression of tissue factor and PAI-1 in endothelial cells. Thromb Haemost. 1999;82(5):1497-1503.

You H, Laychock SG. Long-term treatment with atrial natriuretic peptide inhibits ATP production and insulin secretion in rat pancreatic islets. Am J Physiol Endocrinol Metab. 2011;300(3):E435-E444. doi: 10.1152/ajpendo.00398.2010

Yusof AP, Yusoff NH, Suhaimi FW, Coote JH. Role of supraspinal vasopressin neurones in the effects of atrial natriuretic peptide on sympathetic nerve activity. Auton Neurosci. 2009;148(1-2):50-54. doi: 10.1016/j.autneu.2009.03.005

Zakeri R, Burnett JC, Sangaralingham SJ. Urinary C-type natriuretic peptide: An emerging biomarker for heart failure and renal remodeling. Clin Chim Acta. 2014;443:108-113. doi: 10.1016/j.cca.2014.12.009

Zakeri R, Burnett JC, Sangaralingham SJ. Urinary C-type natriuretic peptide: an emerging biomarker for heart failure and renal remodeling. Clin Chim Acta. 2015;443:108-113. doi: 10.1016/j.cca.2014.12.009

Zhang Q, Moalem J, Tse J, Scholz PM, Weiss HR. Effects of natriuretic peptides on ventricular myocyte contraction and role of cyclic GMP signaling. Eur J Pharmacol. 2005;510(3):209-215. doi: 10.1016/j.ejphar.2005.01.031

Zhang Z, Xiao Z, Diamond SL. Shear stress induction of C-type natriuretic peptide (CNP) in endothelial cells is independent of NO autocrine signaling. Ann Biomed Eng. 1999;27(4):419-426.

Zhao Z, Ma L. Regulation of axonal development by natriuretic peptide hormones. Proc Natl Acad Sci USA. 2009;106(42):18016-18021. doi: 10.1073/pnas.0906880106